Price
$80.84-12.98%Social Signal Score
Analyst Ratings
41 analysts52-week range
- Last close
- $80.84
- Off 52w high
- -26.9%
- 200-day average
- $89.36
- vs 200-day
- -9.5%
Revenue
$108.40B+135.80%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- J. David Joyner
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Employees
- 259,500
- Beta
- 0.58
- Country
- US
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 2.47
Financials
Revenue
$108.40B+135.8%Net Income
$2.17B+27.2%EBITDA
$4.73B+30.3%Free Cash Flow
$3.91B+159.8%EPS (diluted)
$1.68+5.7%Shares Outstanding (diluted)
1.29B+20.8%Cash & Debt
$14.89BReturn of Capital
$853.00MRevenue by Segment (annual)
$389.16BDividend per Share
$0.67Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $402.07B | $1.77B | $1.40 |
| 2024 | $372.81B | $4.61B | $3.66 |
| 2023 | $357.78B | $8.34B | $6.49 |
| 2022 | $322.47B | $4.31B | $3.29 |
| 2021 | $292.11B | $8.00B | $6.00 |
| 2020 | $268.71B | $7.18B | $5.48 |
| 2019 | $256.78B | $6.63B | $5.10 |
| 2018 | $194.58B | $-594.00M | $-0.57 |
| 2017 | $184.79B | $6.62B | $6.47 |
| 2016 | $177.55B | $5.32B | $4.93 |
| 2015 | $153.29B | $5.24B | $4.66 |
| 2014 | $139.37B | $4.64B | $3.98 |
| 2013 | $126.76B | $4.59B | $3.77 |
| 2012 | $123.12B | $3.86B | $3.05 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CVS's reported EPS growth of -5.8% a year over 13 years.
- EPS in 5 years
- $1.04
- Implied price
- $59.00
- Return from $80.84
- -6.1% a year
To earn 15.0% a year on these assumptions you'd need to buy at $29.33 — -63.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 39 | 48 | 57 | 66 | 75 |
|---|---|---|---|---|---|
| -15.8% | -22.2% | -18.9% | -16.1% | -13.6% | -11.3% |
| -10.8% | -17.6% | -14.1% | -11.1% | -8.4% | -6.1% |
| -5.8% | -13.0% | -9.3% | -6.1% | -3.3% | -0.8% |
| -0.8% | -8.3% | -4.5% | -1.1% | 1.8% | 4.5% |
| 4.2% | -3.7% | 0.4% | 3.9% | 7.0% | 9.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
10-84.81%Social Signal Score
Mentions (100)
- News (RSS)marketwatch·2d ago·Negative
Investors fled to healthcare stocks for safety. Now insurance and hospital shares are plunging. Shares of UnitedHealth, Humana and CVS Health declined this week in light of a new Medicare for All proposal
View source ↗ - News247wallst.com·4d ago·Neutral
CVS Health Raised Its 2026 Outlook 3 Times, but Not Its Dividend CVS has the cash, the earnings momentum, and a recovering Aetna, yet shareholders have collected the same payout for 12 straight quarters. Management has other priorities first, and a planned breakup could complicate the answer.
View source ↗ - News (RSS)fortune·5d ago·Neutral
The man who sold Aetna to CVS for almost $70 billion says the deal was cover for problems ‘they never really fixed’—just as CVS breaks itself in two Oscar Health CEO Mark Bertolini says CVS bought Aetna to cover its own problems, two weeks after CVS said it will split in two.
View source ↗ - Newszacks.com·5d ago·Positive
Why CVS Health (CVS) is a Top Growth Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newsfool.com·7d ago·Positive
CVS Health: 3 Key Takeaways for Long-Term Investors CVS Health plans to separate into two independent publicly traded companies. Management raised 2026 adjusted earnings per share guidance to at least $8.20.
View source ↗ - News (RSS)investing·8d ago·Neutral
CVS says GLP-1s save money when priced below $350 per month
View source ↗ - News (RSS)barrons·9d ago·Negative
CVS Breakup Won’t Satisfy Washington. It Could Still Work for Wall Street. Spinning off its drugstores won’t quiet CVS’s critics, but it could leave shareholders with a more valuable company.
View source ↗ - Newswsj.com·9d ago·Negative
CVS Breakup Won't Satisfy Washington. It Could Still Work for Wall Street. Spinning off its drugstores won't quiet CVS's critics, but it could leave shareholders with a more valuable company.
View source ↗ - Newszacks.com·10d ago·Neutral
Can CVS Health's 2028 Split Unlock Value Despite Execution Risks? CVS Health's planned 2028 split aims to sharpen strategic focus, improve capital allocation and unlock growth, but execution costs and operational risks remain.
View source ↗ - Newsseekingalpha.com·11d ago·Positive
CVS Health Corporation (CVS) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript CVS Health Corporation ( CVS ) 8th Annual Wolfe Research Healthcare Conference November 9, 2026 8:45 AM EST Company Participants J. Joyner - CEO, President & Chairman Prem Shah - Executive VP & Group President Conference Call Participants Justin Lake - Wolfe Research, LLC Presentation Justin Lake Wolfe Research, LLC My name is Justin Lake.
View source ↗ - Newsprnewswire.com·11d ago·Neutral
CVS Health earns global recognition for industry-leading AI and technology innovation Seven Stevie® Awards honor innovations across enterprise AI portfolio, including clinical operations, disaster response and workforce development WOONSOCKET, R.I., Nov. 11, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS ) is being recognized with seven Stevie® Awards for technology and responsible AI innovations that are simplifying access to care, supporting colleagues in their work, and helping communities respo…
View source ↗ - Newszacks.com·12d ago·Positive
All You Need to Know About CVS Health (CVS) Rating Upgrade to Buy CVS Health (CVS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗ - News (RSS)ft·12d ago·Negative
CVS break-up shows how M&A-first strategy is not the healthiest option Despite touting better customer outcomes as well as major financial benefits, its stock price has underperformed
View source ↗ - Newsmarketbeat.com·13d ago·Neutral
CVS Health CEO Pushes Back on $1 Billion Split Cost Estimate, Outlines Growth Plans CVS Health NYSE: CVS executives said the company's planned separation of its pharmacy business will create two companies capable of growing independently, while addressing investor questions about the costs and competitive implications of the transaction.
View source ↗ - Newsprnewswire.com·13d ago·Neutral
CVS Pharmacy® makes holiday shopping easier with gifts for every list, budget and celebration WOONSOCKET, R.I., Nov. 9, 2026 /PRNewswire/ -- CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), is helping shoppers take on the holidays with gifts, décor, stocking stuffers, personalized photo favorites and festive essentials for everyone on their list and every budget.
View source ↗ - News (RSS)seekingalpha·14d ago·Neutral
Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focus
View source ↗ - News (RSS)latimes·16d ago·Neutral
Hiltzik: CVS unwinds its big mergers, ending a dream of healthcare dominance CVS thought bigness would be better, but it turned out to be wrong.
View source ↗ - Newsseekingalpha.com·16d ago·Neutral
CVS Health: The Breakup Puts A Price On The Pharmacy CVS Health will split into two public companies by 1H 2028, separating its pharmacy and health services businesses in a tax-free transaction. I estimate intrinsic value at $90–$100 per share, 13–25% above current levels, based on sum-of-the-parts analysis and 2026–2027 guidance. CVS guides 2026 adjusted EPS to at least $8.20, with a 2027 floor of $8.65, and resumes buybacks with $11.5B authorized.
View source ↗ - News (RSS)thestreet·17d ago·Negative
Mark Cuban says CVS breakup may not make prescriptions more affordable Wall Street sees change, but will consumers really pay less for their medications?
View source ↗ - Newsnypost.com·17d ago·Neutral
Here's how CVS' breakup of its pharmacy and insurance empire could affect consumers CVS' recent decision to divide its retail pharmacies from its insurance and pharmacy-benefit operations has raised hopes of consumer savings as Americans continue to reel from high costs of living.
View source ↗ - News (RSS)thestreet·17d ago·Neutral
CVS split leaves shareholders with two stocks and three big questions CVS Health shareholders will own both halves of the breakup. 3M’s split shows why the fine print matters more than the headline.
View source ↗ - Newszacks.com·17d ago·Positive
CVS Health Q3 Earnings Call Focuses on Planned Pharmacy Separation CVS plans to separate its retail pharmacy business by 2028 as stronger Q3 earnings, raised 2026 guidance and Aetna's recovery shape its outlook.
View source ↗ - News (RSS)forbes·17d ago·Negative
CVS Health To Unbundle Pharmacies From Insurance And Health Solutions After building a healthcare conglomerate around a drugstore chain, CVS is dismantling the model with drug stores on one side and healthcare solutions on the other.
View source ↗ - News (RSS)economist·17d ago·Neutral
The break-up of CVS marks a turning point in American health care The trend towards vertical integration may soon reverse
View source ↗ - Newsfool.com·17d ago·Neutral
Huge News for CVS Stock Investors Divesting the company's business units into smaller segments could have significant implications.
View source ↗ - News (RSS)ft·17d ago·Neutral
CVS bets on break-up to dodge political backlash against healthcare giants Bipartisan campaign targeting consolidated ownership of pharmacies, insurers and prescription drug managers weighs on sector
View source ↗ - Newsseekingalpha.com·17d ago·Positive
CVS Health: Strong Quarter, But Breakup Raises Questions CVS Health Corp (CVS) remains a long-term buy, with shares deeply undervalued despite recent volatility and a planned business split. Q3/26 results exceeded expectations: revenue grew 5.4% to $108.4B, adjusted EPS rose 30.7% to $2.09, and guidance was raised. CVS will split into two public companies—CVS Health (insurance, PBM, care) and CVS Pharmacy (retail, clinics)—by H1 2028, aiming for agility and efficiency.
View source ↗ - Newsseekingalpha.com·17d ago·Positive
CVS Health Corporation: Separation Noise Meets Improving Fundamentals - Buy The Meltdown Margin recovery across the insurance/retail pharmacy segments underscore CVS' successful turnaround story, as they hint at double-digits EPS growth through FY2028. These are thanks to the new management team's disciplined insurance underwriting/pricing actions and the retail pharmacy's improved affordability. The separation introduces near-term noise/restructuring costs, but may unlock value by enabling the …
View source ↗ - Newsmarketbeat.com·17d ago·Neutral
What CVS Health (CVS) Said on Its Q3 Earnings Call CVS Health NYSE: CVS plans to separate its retail pharmacy operations from its insurance and pharmacy services businesses, creating two publicly traded companies in a transaction expected to close in the first half of 2028.
View source ↗ - Newsfoxbusiness.com·17d ago·Negative
CVS announces major breakup, pharmacy expert weighs impact on consumers CVS Health breakup will create separate pharmacy and health care companies as industry expert weighs the impact on prescription drug prices, pharmacies and patients.
View source ↗ - News (RSS)barrons·18d ago·Neutral
Stocks Surge, Oil Plummets on Democrat Victory Plus, CVS decides to break itself up.
View source ↗ - Newswsj.com·18d ago·Negative
Inside CVS Health, a small group of top executives spent months engaged in a strategic review that developed into a secret plan: a decision to split up the $400 billion healthcare giant The company is splitting its drugstore and insurance businesses amid mounting regulatory pressure.
View source ↗ - News (Finnhub)CNBC·18d ago·Positive
Why we're kicking CVS out of our Bullpen watchlist. Plus, Intel's CEO makes a stand Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
View source ↗ - News (RSS)forbes·18d ago·Negative
CVS Split Could Push UnitedHealth Group To Sell Or Split Off Assets News that CVS Health was splitting into two companies could pressure UnitedHealth Group and others to sell off some assets or separate them into a new company.
View source ↗ - Newsfastcompany.com·18d ago·Neutral
CVS is splitting into two companies: Healthcare giant's ‘Pharmacy' breakup explained CVS is breaking up.
View source ↗ - 4chan /biz/biz·18d ago·Neutral
just slurped CVS
View source ↗ - 4chan /biz/biz·18d ago·Neutral
should I get CVS slurpies?
View source ↗ - News (RSS)guardian·18d ago·Positive
CVS Health to split pharmacy chain from health insurance CVS Pharmacy will be separate from CVS Health, housing major insurer Aetna and benefits manager CaremarkCVS Health, the largest US healthcare conglomerate valued at $117bn, has announced its plans split off its pharmacy chain from its health insurance and benefits businesses, ending an era in which healthcare companies grew into vast conglomerates.In their announcement on Wednesday, CVS Health said they will split off its 9,000 pharmacies,…
View source ↗ - News (Marketaux)thestockmarketwatch.com·18d ago·Neutral
Market Surges on Earnings Momentum and Economic Optimism CVS Health Corpora[+304 characters]
View source ↗ - Newscnbc.com·18d ago·Positive
CVS Health plans to split itself up. Here's why a breakup could make sense now CVS Health announced plans to split into two publicly traded companies by the first half of 2028, separating its pharmacy business from its insurer, Aetna, and pharmacy benefit manager, Caremark. Analysts say that after a roughly two-year turnaround the company's retail pharmacy business and other units may be strong enough to stand on their own.
View source ↗ - News (RSS)marketwatch·18d ago·Neutral
CVS Health plans to split in two. Here’s what is driving the massive healthcare breakup. The healthcare giant surprised analysts with the decision to separate its business. Its stock is down.
View source ↗ - News (RSS)investing·18d ago·Neutral
CVS Health to split in two, separating pharmacy business from insurance
View source ↗ - News (RSS)nyt·18d ago·Neutral
CVS to Split Off Pharmacy Business, Ending the Healthcare Conglomerate Era In a breakup planned for 2028, CVS Health intends to split off its pharmacies into a new company, while keeping together its businesses in insurance and pharmacy benefits.
View source ↗ - News247wallst.com·18d ago·Neutral
CVS Is Breaking Itself Up. Here's What That Means for Your Healthcare ETF CVS just announced a plan to split into two separate public companies, and if you own a healthcare ETF, a dividend fund, or an S&P 500 index fund, your portfolio is already caught in the middle of what happens next.
View source ↗ - Newszacks.com·18d ago·Positive
CVS Q3 Earnings & Revenues Top Estimates, Stock Up in Pre-Market CVS Health's Q3 earnings and revenues beat estimates as stronger margins and improved operating performance prompt management to raise its 2026 outlook.
View source ↗ - Newsseekingalpha.com·18d ago·Positive
CVS Health Corporation (CVS) Q3 2026 Earnings Call Transcript CVS Health Corporation (CVS) Q3 2026 Earnings Call Transcript
View source ↗ - News (RSS)wsj·18d ago·Negative
Democrats Take Congress as Trump Says Iran War Is Partly to Blame for GOP Losses Plus, Iran turns to guerrilla tactics to try to stop the flow of oil leaving the Strait of Hormuz, and CVS Health decides to split in two.
View source ↗ - News (RSS)investing·18d ago·Neutral
Why is CVS Health stock sliding today?
View source ↗ - Newszacks.com·18d ago·Positive
CVS Health (CVS) Beats Q3 Earnings and Revenue Estimates CVS Health (CVS) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.6 per share a year ago.
View source ↗ - News247wallst.com·18d ago·Negative
CVS Is Reportedly Breaking Itself in Two Reports say CVS Health is weighing a split that would unwind its landmark Aetna merger, but the structure, timeline, and who absorbs billions in debt remain unanswered questions heading into a critical earnings call.
View source ↗ - News (RSS)forbes·18d ago·Negative
CVS Health To Split Into Two Companies As Pressure Mounts On Vertical Integration CVS Health will split into two companies, putting its more than 9,000 drugstores under one business and its Aetna health insurance and pharmacy benefit operations into another.
View source ↗ - Newswsj.com·18d ago·Positive
CVS Raises Forecast on Health Care Benefits, Pharmacy Gains CVS Health raised its full-year guidance on gains in its health-care benefits and pharmacy segments, but said it remains cautious amid high costs and potential macroeconomic headwinds.
View source ↗ - Newscnbc.com·18d ago·Negative
CVS to split off drugstore business in major breakup of healthcare giant CVS Health plans to split into two separate public companies by early 2028, in what would be one of the largest corporate splits in history. The move would specifically reverse the company's massive $78 billion acquisition of its insurer, Aetna, and dismantle the vertically integrated healthcare conglomerate it created in 2018.
View source ↗ - Newsprnewswire.com·18d ago·Positive
CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare A leading healthcare solutions company with health benefits, pharmacy services and care delivery The leading national retail pharmacy and community healthcare company Ongoing strategic execution creates opportunity for CVS Health to evolve into two companies with greater focus and more value for stakeholders Will continue to improve affordability, access, and simplicity in healthcare Both companies expected to have a solid …
View source ↗ - Newsbarrons.com·18d ago·Neutral
CVS Reveals Plan to Split Insurance and Pharmacy Businesses, Earnings to Come CVS said it would split into two companies as Wall Street awaits third-quarter adjusted earnings which are expected at $1.65 a share.
View source ↗ - News (RSS)investing·18d ago·Neutral
CVS Health to break up into two companies, WSJ reports
View source ↗ - News (RSS)ft·19d ago·Negative
CVS Health moves to dismantle $117bn healthcare empire Potential spin-off of drugstore business comes as political pressure mounts on pharmacy benefit managers and health insurers
View source ↗ - Newsnypost.com·19d ago·Neutral
CVS breaking up its healthcare empire — splitting pharmacies from insurance business A separation would mark a significant reversal of CVS' strategy of building an integrated healthcare business through acquisitions, including its roughly $78 billion purchase of health insurer Aetna in 2018.
View source ↗ - Newswsj.com·19d ago·Neutral
CVS Health will split into two companies, dividing its retail pharmacies from its insurance and pharmacy-benefit operations The company will split its retail pharmacies from its insurance and pharmacy-benefit operations.
View source ↗ - News247wallst.com·19d ago·Neutral
‘Too Cheap to Ignore'? What to Watch When CVS and McDonald's Report Jim Cramer called CVS too cheap to ignore and McDonald's the cheapest it has been since 2014, but both stocks still carry real risks that their upcoming earnings reports will either confirm or crush.
View source ↗ - News (RSS)zerohedge·20d ago·Neutral
…rvices PMICentral banks: Riksbank decision, ECB's Lane and Moulin speak, BoJ minutes of the September meetingEarnings: ARM, QUALCOMM, McDonald's, Novo Nordisk, Uber, CVS Health, McKesson, Datadog, Emerson Electric, AppLovin, MercadoLibre, Coherent, BMW, Expedia, Leonardo, Kraft Heinz, Fair Isaac, VonoviaAuctions: US Treasury quarterly refunding announcementThursday November 5Data: US Q3 nonfarm productivity, unit labor costs, initial jobless claims, UK October new car registrations, construction…
View source ↗ - News (RSS)zerohedge·20d ago·Neutral
…rvices PMICentral banks: Riksbank decision, ECB's Lane and Moulin speak, BoJ minutes of the September meetingEarnings: ARM, QUALCOMM, McDonald's, Novo Nordisk, Uber, CVS Health, McKesson, Datadog, Emerson Electric, AppLovin, MercadoLibre, Coherent, BMW, Expedia, Leonardo, Kraft Heinz, Fair Isaac, VonoviaAuctions: US Treasury quarterly refunding announcementThursday November 5Data: US Q3 nonfarm productivity, unit labor costs, initial jobless claims, UK October new car registrations, construction…
View source ↗ - News247wallst.com·21d ago·Negative
After He Returned From The Pacific Theater, A World War II Vet Bought $1,000 Of Walgreen Stock. 7 Decades Later, Russ Gremel’s $1,000 Investment Had Grown To Over $2 Million A Chicago lawyer who survived the Pacific Theater came home, put a modest sum into his neighborhood drugstore, and never touched it again. What he eventually did with the fortune he quietly built stunned everyone who knew him.
View source ↗ - Newszacks.com·23d ago·Negative
Countdown to CVS Health (CVS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS Besides Wall Street's top-and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.
View source ↗ - News (RSS)zerohedge·25d ago·Neutral
… a sampling of insurance contracts by the Government Accountability Office in 2018.Five companies account for 77 percent of all 340B pharmacy relationships. They are CVS Health, Walgreens, Walmart, Cigna, and UnitedHealth Group, according to the Drug Channels Institute, a pharmaceutical intelligence company."These Fortune 50 companies profit from 340B transactions without directly supporting the program's safety-net mission," wrote a team of scholars at the University of Southern California Scha…
View source ↗ - Newsseekingalpha.com·25d ago·Positive
CVS Q3 Preview: Accelerating Growth, Near 3% Yield, Meaningful Upside Long-Term CVS Health has executed a robust turnaround, prompting an upgrade from hold to buy with a $115 price target. Accelerating earnings, raised guidance, improved margins, and reduced leverage underpin a strengthened long-term investment case for CVS. Dividend safety is enhanced by strong free cash flow and a low payout ratio, supporting income investors amid potential volatility.
View source ↗ - Newszacks.com·25d ago·Neutral
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
View source ↗ - Newszacks.com·26d ago·Neutral
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors CVS Health (CVS) closed the most recent trading day at $91.13, moving 1.51% from the previous trading session.
View source ↗ - News (RSS)fool·27d ago·Positive
Should You Buy CVS Health Stock While It's Under $100? CVS Health stock is down 16% from its 52-week high, and it trades at a relatively modest valuation.
View source ↗ - Newsfool.com·27d ago·Positive
Should You Buy CVS Health Stock While It's Under $100? After a couple of challenging years, CVS Health has been generating some improved numbers in 2026. The company is expecting a significant improvement on the bottom line this year.
View source ↗ - Newszacks.com·27d ago·Neutral
CVS Health Q3 Earnings Preview: How to Approach the Stock? CVS' third-quarter 2026 results face mixed segment trends, with Aetna's margin recovery and digital investments offering support amid persistent 340B pressures and membership declines.
View source ↗ - News (RSS)thestreet·29d ago·Negative
CVS wants to be more like Costco and Marshalls The struggling pharmacy chain plans to give customers a reason to visit even when they're not picking up a prescription.
View source ↗ - News (RSS)seekingalpha·30d ago·Positive
CVS Caremark, Express Scripts, Optum Rx targeted in House investigation
View source ↗ - Newszacks.com·30d ago·Positive
Is Trending Stock CVS Health Corporation (CVS) a Buy Now? CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - Newsprnewswire.com·30d ago·Neutral
CVS Pharmacy expands fall assortment of collectibles, nostalgic favorites and seasonal exclusives New and expanded offerings across toys, collectibles, beauty, snacks and seasonal categories give shoppers more opportunities to discover unexpected finds WOONSOCKET, R.I., Oct. 23, 2026 /PRNewswire/ -- CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), today announced an expanded assortment of collectibles, nostalgic favorites, limited-edition products and seasonal finds for fall, intro…
View source ↗ - News (RSS)thestreet·33d ago·Positive
CVS targets former Walgreens, Rite Aid customers after 1,000 stores close The national pharmacy retail chain is making a push to win over customers that rivals have abandoned.
View source ↗ - Newsprnewswire.com·33d ago·Neutral
… expand access to convenient, affordable health care services Charlestown marks first MinuteClinic location in Boston WOONSOCKET, R.I., Oct. 20, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that MinuteClinic ®, the medical clinic inside select CVS Pharmacy® locations, has opened three new locations in Charlestown, Beverly and Swampscott, to help increase access to health care services for patients in those communities.
View source ↗ - News247wallst.com·34d ago·Neutral
3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking Retirement planning gets harder when healthcare coverage becomes a moving target. A familiar insurance card can mean access to trusted doctors, predictable prescription costs, and benefits that help stretch a fixed income.
View source ↗ - News (RSS)seekingalpha·35d ago·Neutral
Notable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus
View source ↗ - Newszacks.com·38d ago·Neutral
CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider The latest trading day saw CVS Health (CVS) settling at $92.17, representing a +1.97% change from its previous close.
View source ↗ - Newsprnewswire.com·38d ago·Negative
CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey New research study will explore the realities and opportunities of midlife and inform an upcoming documentary WOONSOCKET, R.I., Oct 15, 2026 /PRNewswire/ -- CVS Health ® (NYSE: CVS) today announced a new collaboration with The Midlife Collective, a media company and community platform dedicated to changing the cultural conversation around women and aging.
View source ↗ - News (RSS)zerohedge·39d ago·Negative
CVS To Pay $315 Million Over Claims It Filled Unlawful Opioid Prescriptions CVS To Pay $315 Million Over Claims It Filled Unlawful Opioid Prescriptions Authored by Kimberly Hayek via The Epoch Times, CVS Pharmacy Inc. and related entities agreed Tuesday to pay $315 million to resolve Justice Department allegations that the company illegally filled opioid and other controlled-substance prescriptions and billed many of them to Medicare and other federal health programs. The sum settles claims that…
View source ↗ - News (Marketaux)seekingalpha.com·39d ago·Neutral
IHF: A Concentrated And Volatile ETF In Healthcare Providers (NYSEARCA:IHF) Ticker Name Weight (%) UNH UNITEDHEALTH [+347 characters]
View source ↗ - News (RSS)barrons·39d ago·Positive
The Morning Risk Report: Bank of America to Pay $1.2 Billion to Settle Violations of Money Laundering, Sanctions Laws Plus: CVS health unit resolves illegal opioid prescription claims and drones struck two commercial ships sailing near NATO waters
View source ↗ - Newsfastcompany.com·39d ago·Positive
CVS to pay $315 million settlement to resolve DOJ opioid lawsuit CVS Pharmacy Inc. and various subsidiaries have agreed to pay $315 million to resolve a Justice Department case alleging it unlawfully dispensed medically unnecessary prescriptions of highly addictive opioids, officials said Tuesday.
View source ↗ - News (RSS)forbes·40d ago·Positive
CVS Will Pay $315 Million To Settle Federal Opioid Case The agreement settles a lawsuit the Justice Department filed back in 2024, claiming CVS improperly filled opioid prescriptions and billed federal health care programs.
View source ↗ - News (RSS)investing·40d ago·Positive
CVS settles US Justice Department case over opioid prescriptions for $315 million
View source ↗ - Newszacks.com·41d ago·Neutral
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy? When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
View source ↗ - News (Marketaux)insidermonkey.com·44d ago·Positive
CVS Health (CVS) vs Cigna (CI): Which is a Better Stock to Buy? CVS Health Corpora[+217 characters]
View source ↗ - Newsbarrons.com·44d ago·Neutral
CVS Stock Dips After Drop in Medicare Advantage Plan Ratings Aetna, the insurance arm of CVS Health, saw its four-star or higher plans lose ground in the latest federal ratings.
View source ↗ - News (RSS)investing·45d ago·Neutral
After-Hours Movers: T, VZ, TMUS, SPCX, HUM, ALHC, CVS, CLOV, UNH, AXP
View source ↗ - Newszacks.com·45d ago·Positive
CVS Health Trades at a Discount to Industry: How to Play the Stock? CVS trades below industry peers as Aetna margins recover, pharmacy trends improve and Health Services gains momentum, but 340B headwinds persist.
View source ↗ - News (RSS)fortune·45d ago·Neutral
Your next manager may have three employees and 19 agents. Who’s accountable? CIOs at CVS, Broadridge and IBM say AI isn't shrinking the manager's job. It's breaking it into pieces and the pieces are landing on non-managers.
View source ↗ - Newszacks.com·45d ago·Positive
Here's Why CVS Health (CVS) is a Strong Growth Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newsbenzinga.com·45d ago·Neutral
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
View source ↗ - Newszacks.com·46d ago·Negative
CVS Health (CVS) Advances While Market Declines: Some Information for Investors In the closing of the recent trading day, CVS Health (CVS) stood at $87.95, denoting a +1.76% move from the preceding trading day.
View source ↗ - Newszacks.com·46d ago·Neutral
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now? CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - News247wallst.com·46d ago·Positive
Why CVS Is ‘Insanely Cheap,' ON Semi a Laggard Catching Up, and Grail Too Expensive to Chase Jim Cramer sees three stocks with very different amounts of bad news or good news already baked into their prices, and figuring out which side each sits on changes everything about whether to buy.
View source ↗ - Newsprnewswire.com·46d ago·Neutral
CVS Health® reminds New Yorkers that MMR vaccines are available statewide amid measles outbreak Eligible patients can receive MMR vaccinations at more than 530 CVS Pharmacy® locations across New York and at MinuteClinic® locations WOONSOCKET, R.I., Oct. 7, 2026 /PRNewswire/ -- As New York responds to an ongoing measles outbreak and statewide disaster emergency, CVS Health® (NYSE: CVS) is reminding residents that measles-mumps-rubella (MMR) vaccinations are available for eligible patients at CVS …
View source ↗ - Newszacks.com·47d ago·Positive
CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead? CVS Health raises its Health Care Benefits outlook as stronger core trends, led by Medicare, support margin recovery despite medical cost pressures.
View source ↗
Earnings
Tue, Feb 9(in 3 months)
Consensus estimate $1.03 per share
Typical surprise +24.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Nov 4$2.09 vs $1.65beat
- Wed, Aug 5$2.58 vs $1.85beat
- Wed, May 6$2.57 vs $2.18beat
- Tue, Feb 10$1.09 vs $1.00beat
- Wed, Oct 29$1.60 vs $1.37beat
- Thu, Jul 31$1.81 vs $1.46beat
Estimates and results for CVS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CVS officers and directors.
- Bought
- $2.1m
- Sold
- $346.3m
6 trades
10 trades
- Shah Prem Sbought
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
84 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Nov 9, 2026 (27d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 9, 2026 (27d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (35d later)Sell$15,001 - $50,000
- Thomas Hawley Tubervillesenate · AL · disclosed Aug 5, 2026 (709d later)Sell$1,001 - $15,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2026 (36d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 11, 2026 (41d later)Buy$1,001 - $15,000
- Dwight Evanshouse · PA03 · disclosed May 15, 2026 (175d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed May 13, 2026 (30d later)Buy$1,001 - $15,000
- John Boozmansenate · AR · disclosed Feb 15, 2026 (17d later)Buy$1,001 - $15,000
- Michael T. McCaulhouse · TX10 · disclosed Feb 12, 2026 (30d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (12d later)Sell$1,001 - $15,000
- Julia Letlowhouse · LA05 · disclosed Jan 13, 2026 (398d later)Sell$1,001 - $15,000
- Julia Letlowhouse · LA05 · disclosed Jan 13, 2026 (445d later)Buy$1,001 - $15,000
- Dwight Evanshouse · PA03 · disclosed Dec 22, 2025 (31d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (24d later)Sell$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Oct 10, 2025 (17d later)Sell$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Sep 12, 2025 (318d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
